You have 9 free searches left this month | for more free features.

ublituximab

Showing 26 - 32 of 32

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Chronic Lymphocytic Leukemia Trial in Israel, United States (Ublituximab, Ibrutinib)

Completed
  • Chronic Lymphocytic Leukemia
  • Huntsville, Alabama
  • +87 more
Apr 25, 2022

Chronic Lymphocytic Leukemia Trial in Worldwide (Obinutuzumab, Ublituximab, TGR-1202)

Active, not recruiting
  • Chronic Lymphocytic Leukemia
  • Obinutuzumab
  • +3 more
  • Huntsville, Alabama
  • +153 more
Aug 19, 2022

DLBCL, Follicular Lymphoma, Marginal Zone Lymphoma Trial in Worldwide (Ublituximab, Umbralisib, Bendamustine)

Terminated
  • Diffuse Large B-Cell Lymphoma
  • +4 more
  • Ublituximab
  • +2 more
  • Birmingham, Alabama
  • +167 more
Jul 20, 2022

Chronic Lymphocytic Leukemia, Non-Hodgkin's Lymphoma Trial in United States (Ublituximab + TGR-1202, Ublituximab + TGR-1202 +

Completed
  • Chronic Lymphocytic Leukemia
  • Non-Hodgkin's Lymphoma
  • Ublituximab + TGR-1202
  • +2 more
  • Huntsville, Alabama
  • +5 more
Nov 4, 2019

Non-Hodgkins Lymphoma, B-cell Lymphoma, Waldenstrom's Macroglobulinemia Trial in United States (Ublituximab)

Completed
  • Non-Hodgkins Lymphoma
  • +6 more
  • Ublituximab
  • Huntsville, Alabama
  • +7 more
Oct 1, 2019

Neuromyelitis Optica, Neuromyelitis Optica Spectrum Disorder Trial in Baltimore (Ublituximab)

Completed
  • Neuromyelitis Optica
  • Neuromyelitis Optica Spectrum Disorder
  • Ublituximab
  • Baltimore, Maryland
    Johns Hopkins University School of Medicine
Jun 5, 2019

Chronic Lymphocytic Leukemia Trial in France (LFB-R603)

Completed
  • Chronic Lymphocytic Leukemia
  • Le Mans, France
  • +8 more
Apr 27, 2012